Join Sherry Mori Vogt, PharmD, BCOP from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic Immunotherapies in Metastatic Bladder Cancer.
Join Steven J. Isakoff, MD, PhD and Kristen Mahoney Shannon, MS, LCGC from Massachusetts General Hospital Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to breast cancer.
Join Bill Loo, MD, PhD and Natalie Lui, MD from Stanford Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to early stage lung cancer.
Join James Stevenson, MD, and Sanjay Mukhopadhyay, MD, from Cleveland Clinic Taussig Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to advanced lung cancer.
Join John D. Pfeifer, MD, PhD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine for this webinar Which Biomarker Test Should I Use? in the NCCN 2017 Congress Series™: Biomarkers 101.
Join Ross Camidge, MD, PhD, University of Colorado Cancer Center for this webinar How Is Biomarker Testing Enriching Patient Populations for Clinical Trials and Impacting Drug Development? in the NCCN 2017 Congress Series™: Biomarkers 101
Join Long Phi Le, MD, PhD, Massachusetts General Hospital for this webinar What Are Biomarker Tests and How Are They Approved? in the NCCN 2017 Congress Series™: Biomarkers 101.
Join Jill Burke, MSN, NP, and Noopur Raje, MD, from Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center as they present their multidisciplinary expertise on a range of cases pertaining to multiple myeloma.
Facebook
X
LinkedIn
Forward
